The levels of Gd-IgA1 in serum or cell supernatants are significantly higher in IgAN patients than in healthy controls and those with non-IgAN kidney diseases, establishing Gd-IgA1 as a reliable diagnostic biomarker for IgAN [249]. This evidence concerns the gene IGHA1 and kidney disorder.